Actionable Stock Market Trading Newswire. Built for Traders, by Traders. All news is property of their respective owners.
HomeNewsfeedsNeurosense Therapeutics Granted European Patent Titled ‘COMPOSITIONS COMPRISING AN ANTI-INFLAMMATORY DRUG AND A DICER ACTIVATOR FOR USE IN THE TREATMENT OF NEURONAL DISEASES (INCLUDING PARKINSON’S AND ALZHEIMER’S DISEASE)’
Neurosense Therapeutics Granted European Patent Titled ‘COMPOSITIONS COMPRISING AN ANTI-INFLAMMATORY DRUG AND A DICER ACTIVATOR FOR USE IN THE TREATMENT OF NEURONAL DISEASES (INCLUDING PARKINSON’S AND ALZHEIMER’S DISEASE)’
Spirit Airlines anticipates first-quarter FY24 revenue slightly below estimates at $1.265 billion. With capital expenditures of $30 million primarily for its new headquarters in Dania Beach, Florida, and spare parts, Spirit remains focused on strategic investments. Ending Q1 with $1.2 billion in cash reserves and a $300 million credit line.